Laparoscopic nephrolithotomy and pyelolithotomy

2.1 Indications

2.1.1 Renal stones are hard masses that form from crystals in urine. They range in size from small gravel-like stones to large stones that extend into more than one calyx (staghorn calculi). Although kidney stones are often asymptomatic, they can cause pain in the abdomen, lower back or groin, and blood in the urine. Depending on its size and position, an untreated stone can obstruct the passage of urine or lead to infection and permanent kidney damage.

2.1.2 Small renal stones will usually pass out of the kidney in the urine without any treatment. However, larger stones and those that cause persistent symptoms may need to be broken into smaller pieces or removed. A variety of techniques are available, depending on the number and size of stones and their site and type. These techniques include open surgery, percutaneous nephrolithotomy (PCNL), ureteroscopic techniques and extracorporeal shockwave lithotripsy.

2.2 Outline of the procedure

2.2.1 Laparoscopic nephrolithotomy and pyelolithotomy are similar procedures, performed under general anaesthesia using a transperitoneal or retroperitoneal approach.

2.2.2 The abdomen is insufflated with an inert gas and small incisions are made to allow insertion of instruments. In laparoscopic nephrolithotomy, incisions are made in the renal capsule and parenchyma (nephrotomy) and the stone or stones are removed from the affected calices. The nephrotomy site may or may not be closed with sutures, and a stent running from the kidney to the bladder may be inserted and left in place for several weeks after surgery. In pyelolithotomy, the stone is removed via an incision in the renal pelvis (pyelotomy), which is usually then closed with sutures, with or without insertion of a stent.

2.3 Efficacy

2.3.1 Two non-randomised controlled trials reported that similar proportions of patients were stone-free after laparoscopic pyelolithotomy and PCNL (88% [14/16] versus 81% [13/16], respectively, in one trial and 100% in both groups [16/16 and 12/12] in the other). A third non-randomised controlled trial of 89 patients reported that none of those treated with laparoscopic pyelolithotomy had residual stones, compared with 13% of patients treated with PCNL. In one case series, 6 of 7 patients were stone-free after treatment. In another, all 8 patients were stone-free 3 months after laparoscopic pyelolithotomy and 7 were still stone-free at 12 months' follow-up.

2.3.2 Three non-randomised controlled trials (149 patients in total) reported mean lengths of hospital stay of 3.9, 6.5 and 3.8 days for laparoscopic pyelolithotomy, compared with 5.4, 5.6 and 3.0 days for PCNL (p = 0.17 in one study; p values were not reported in the other studies). Two of these non-randomised controlled trials reported that the mean time to return to normal activities was 13 days after laparoscopic pyelolithotomy (both studies), compared with 14 and 10 days after PCNL (p values not reported; not significant, respectively).

2.3.3 The Specialist Advisers noted that these procedures are likely to be suitable for only a small proportion of patients with renal stones. They also noted that both experience in stone management and special training in laparoscopic surgery are necessary to carry out this procedure.

2.4 Safety

2.4.1 Two non-randomised controlled trials reported peritoneal tears in 12% (5/43) and 19% (3/16) of patients treated with laparoscopic pyelolithotomy using a retroperitoneal approach, but in none of the patients treated with PCNL. Peritoneal tears may lead to a requirement for conversion to open surgery, due to loss of operative space. Conversion to open surgery was required in 1 of the 8 reported cases in these two studies. Three studies reported urinary leakage (not further defined) in 7% (1/15), 10% (2/20) and 13% (2/16) of patients treated laparoscopically.

2.4.2 Three non-randomised controlled trials reported that 13–16% of laparoscopic pyelolithotomy procedures (7/43 and 2/16 in two separate studies) had to be converted to open surgery, compared with 0–2% of percutaneous procedures (1/48, 0/16, 0/12). In one case series, none of eight laparoscopic procedures required conversion to open surgery; in another, 20% (4/20) were converted to open surgery.

2.4.3 The Specialist Advisers listed potential adverse events as the need for nephrectomy or conversion to open surgery, urinary fistula, urinary leakage, haemorrhage and infection.

2.5 Other comments

2.5.1 It was noted that procedures of this kind are seldom needed, as most renal stones can be managed in other ways. The fact that these technically advanced procedures are likely to be used infrequently underpins the recommendation in section 1.2.

Andrew Dillon
Chief Executive
March 2007